|
Zoloft Crestor Cialis Wellbutrin Effexor Celebrex Levitra Neurontin Paxil Zocor Recent updates to the Drugs.com website and database Consumer and prescribing information. Atripla, Azilect, Brovana, Cesamet, Chantix, Duetact, Fentora, Implanon, Ionsys, Januvia, Lucentis, Magnevist, Noxafil, Opana, Oracea, Prezista, Solodyn, Sprycel, Tamiflu, Tyzeka, Vectibix, Zelapar, Zolinza... New Application: RenvelaDecember 21, 2006 - Genzyme Corp. announced today that it has filed a New Drug Application with the FDA seeking approval of sevelamer carbonate for the control of serum phosphorus in patients with chronic kidney disease on dialysis. Sevelamer carbonate will be marketed under the trade name Renvela. Renvela is being developed as a next generation phosphate binder to replace... New Approval: CombiganDecember 22, 2006 - Allergan Inc. today announced that the FDA issued an approvable letter for Combigan for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. An approvable letter outlines the remaining conditions that a company... New Application: Xcytrin December 23, 2006 - Pharmacyclics, Inc. has announced that it has submitted a New Drug Application for Xcytrin Injection with the FDA. The company is seeking approval to market Xcytrin for the treatment of non-small cell lung cancer (NSCLC) patients with brain metastases (i.e., cancer that has spread to the brain from another part of the body). Xcytrin is a redox-active... New Application: Vyvanse_ D
| Ultram medicine | Ultram abuse | Cheap online order ultram | Ultram withdrawal | Ultracet ultram hydrocodone valium pain relief che | Ultram 50 mg | Ultram dosage | [ Phentermine ]
|
